Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa
- 1 July 2000
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 356 (9223), 41
- https://doi.org/10.1016/s0140-6736(00)02434-x
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CThe New England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CThe New England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998